Piciocchi A

31PUBLICATIONS
169CO-AUTHORS
Medical infection agents (incl. prions)NanomedicinePredictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Nov 01, 2026
Prognostic Impact of FLT3-ITD Microclones in AML: An EHA AML-Specialized Working Group Study.

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Jun 18, 2026
Vaccination and Antiviral Combination Improves Resolution Time of COVID-19 Infection in Treated Multiple Myeloma: A Retrospective Study.

|Mar 06, 2026
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia.

Niccolò Bartalucci, Francesco Mannelli, Danilo Tarantino

|Mar 05, 2026
Validation of ICC hierarchical classification in secondary AML.

Enrico Attardi, Marta Cipriani, Luca Guarnera

|May 07, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.

Anna Sicuranza, Massimo Breccia, Francesco Iuliano

Pageof 6

Frequent Collaborators

10 joint publications

Adriano Venditti

10 joint publications

Maria Teresa Voso

9 joint publications

Marco Vignetti

5 joint publications

Monica Bocchia